Cargando…
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
BACKGROUND: Predictive markers can help tailor treatment to the individual in metastatic renal cell carcinoma (mRCC). De Ritis ratio (DRR) is associated with oncologic outcomes in various solid tumors. OBJECTIVE: To assess the value of DRR in prognosticating survival in mRCC patients treated with ty...
Autores principales: | Janisch, Florian, Klotzbücher, Thomas, Marks, Phillip, Kienapfel, Christina, Meyer, Christian P., Yu, Hang, Fühner, Constantin, Hillemacher, Tobias, Mori, Keiichiro, Mostafei, Hadi, Shariat, Shahrokh F., Fisch, Margit, Dahlem, Roland, Rink, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405478/ https://www.ncbi.nlm.nih.gov/pubmed/33649869 http://dx.doi.org/10.1007/s00345-021-03628-2 |
Ejemplares similares
-
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data
por: Janisch, Florian, et al.
Publicado: (2021) -
The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy
por: Quhal, Fahad, et al.
Publicado: (2020) -
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
por: Janisch, Florian, et al.
Publicado: (2019) -
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020) -
Female with bladder cancer: what and why is there a difference?
por: Marks, Phillip, et al.
Publicado: (2016)